The effect of recombinant human interferon α B/D compared to interferon α 2b on SIV infection in rhesus macaques.

Antiviral Research

Volumn 32, Issue 1, 1996, Pages 1-8

  Schellekens, H ^a   Niphuis, H ^b   Buijs, L ^b   Douw Van Der Krap, P ^a   Hochkeppel, H K ^c   Heeney, J L ^b  

^a REINIER DE GRAAF HOSPITAL   (Netherlands)

^b BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

AIDS; HIV; Interferon; Rhesus monkey; SIV

Indexed keywords

RECOMBINANT ALPHA INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT ALPHAB/D INTERFERON; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALIA; MACACA MULATTA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0030222312     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00955-8     Document Type: Article

References (22)

1. Caliendo, A.M. and Hirsch, M.S. (1994) Combination therapy for infection due to human immunodeficiency virus type 1. Clin. Infect. Dis. 18, 516-524.
2. De Wit, R., Boucher, C.A.B., Veenhof, K.H.N., Schattenkerk J.K.M.E., Bakker P.J.M. and Danner, S.A. (1988) Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma. The Lancet 11, 1214-1217.
3. Fauci, A.S. (1993) Multifactorial nature of HIV disease: implications for therapy. Science 262, 1011-1018.
4. Fazely, F., Haseltine, W.A., Rodger, R.F. and Ruprecht, R.M. (1991) Postexposure chemoprophylaxis with ZDV or ZDV combined with interferon-α: failure after inoculating rhesus monkeys with a high dose of SIV. J. Acquir. Immune Defic. Syndr. 4, 1093-1097.
5. Fischl, M.A., Uttamchandani, R.B., Resnick, L., Agarwal, R., Fletcher, M.A., Patrone-Reese, J., Dearmas, L., Chidekel, J., McCann, M. and Myers, M. (1991) A phase I study of recombinant human Interferon-α 2a or human lymphoblastoid interferon-α n1 and concomitant Zidovudine in patients with AIDS-related Kaposi's sarcoma. J. Acquir. Immune Defic. Syndr. 4, 1-10.
6. Giannelli, G., Antonelli, G., Fera, G., Del Vecchio, S., Riva, E., Broccia, C., Schiraldi, O. and Dianzani, F. (1994) Biological and clinical significance of neutralizing and binding antibodies to interferon α (IFN-α) during therapy for chronic hepatitis C. Clin. Exp. Immunol. 97, 4-9.
7. Kawade, Y. and Watanabe, Y. (1984) Neutralization of interferon by antibody: appraisal of methods of determining and expression the neutralization titer. J. Interferon Res. 4, 571-584.
8. Krown, S.E., Real, F.X., Cunningham-Rundles, S., Myskowski, P., Koziner, B., Fein, S., Mittelman, A., Oettgen, H.F. and Safai, B. (1983) Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. N. Eng. J. Med. 308, 1071-1076.
9. Krown, S.E. (1986) Interferons and interferon inducers in cancer treatment. Semin. Oncol. 13, 207-217.
10. Lane, H.C. (1994) Interferons in HIV and related diseases. AIDS Suppl. 3, S19-23.
11. Lane, H.C., Davey, V., Kovacs, J.A., Feinberg, J., Metcalf, J.A., Herpin, B., Walker, R., Deyton, L., Davey Jr., T. and Falloon, J. (1990) Interferon-α in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial. Intern. Med. 112, 805-811.
12. Murphey-Corb, M., Martin, L.N., Rangan, S.R.S., Baskin, G.B., Gormus, B.J., Wolf, R.H., Andes, W.A., West, M. and Montelaro, R.C. (1986) Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys. Nature 321, 435.
13. Murphey-Corb, M., Martin, L.N., Davison-Fairburn, B., Montelaro, R.C., Miller, M., West, M., Ohkawa, S., Baskin, G.B., Zhang, J.Y., Putney, S.D., Allison, A.C. and Eppstein, D.A. (1989) A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 246, 1293-1297.
14. Nakano, Y., Kiyosawa, K., Sodeyama, T. and Tanaka, E. (1990) Comparative study of clinical, histological, and immunological responses to interferon therapy in type non-A, non-B, and type B chronic hepatitis. Am. J. Gastroenterol. 85, 24-29.
15. Nathan, C.F. (1986) In: L Gresser and J. Vilcek, (Eds), Interferon 9, pp 125-143, Academic Press, New York.
16. Poli, G., Biswas, P. and Fauci, A.S. (1994) Interferons in the pathogenesis and treatment of human immunodeficiency virus infection. Antiviral Res. 24, 221-233.
17. Schellekens, H. and Horzinek, M.C. (Eds) (1990) Animal Models in AIDS. Elsevier Science Publishers, Amsterdam.
18. Schneider, H.T. and Goldman, U. (1989) Antiviral effects of recombinant interferon α and clinical experience on viral infections. Arzneim.-Forsch./Drug Res. 39 (II), 1608.
19. Spiegel, R.J. (1986) Interferon alpha 2b: clinical overview and future directions. Semin. Oncol. 13 (Suppl. 2), 89-101.
20. Van der Meide, P.H., Dubbeld, M. and Schellekens, H. (1985) Monoclonal antibodies to human immune interferon and their use in a sensitive solid-phase ELISA. J. Immunol. Methods 79, 293-305.
21. Volberding, P.A., Mitsuyasu, R.T., Golando, J.P. and Spiegel, R.T. (1987) Treatment of Kaposi's sarcoma with interferon α-2b (Intron A). Cancer 59, 620-625.
22. Wachter, H. and Hunsmann, G. (1989) Urinary neopterin concentrations in rhesus monkeys after infection with simian immunodeficiency virus (SIVmac 251). AIDS 3, 305-307.